In the Highlights
November 2023
Our CEO & Co-Founder Nahum Ferera on the Odelle Technology Podcast
Our CEO & Co-Founder Nahum Ferera on the Odelle Technology Podcast
Read
February 2022
Therapeutic contact lens for Fuchs endothelial corneal dystrophy: Monitoring with Scheimpflug tomography
This case report demonstrates the effectiveness of a combined unique soft contact lens design and hypertonic saline at reducing corneal edema symptoms.
Read
February 2021
EndoArt Received the Breakthrough Device Designation from the FDA
Our revolutionary EndoArt® received the Breakthrough Device Designation from the FDA.
ReadNews
September 2020
A new type of corneal availability
All you wanted to know about the disruptive EndoArt Artificial Endothelial Layer (and some more….).
Read
February 2020
EndoArt® receives the Breakthrough Device Designation from the FDA
Our revolutionary EndoArt® receives the Breakthrough Device Designation from the FDA. A very meaningful milestone in the path to the market
ReadEvents
September 2023
ESCRS 2023
Our CEO, Nahum Ferera is at the Ophthalmology Futures Forum at the Hilton Danube in Vienna, as part of the annual The European Society of Cataract and Refractive Surgeons (ESCRS) Congress.
Read